You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FLT3 positive Acute Myeloid Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia Trial in Wuhan (T cell injection targeting FLT3 chimeric antigen

Recruiting
  • FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
  • T cell injection targeting FLT3 chimeric antigen receptor
  • Wuhan, Hubei, China
    Union Hospital, affiliated with TongJi Medical College, HuaZhong
Jun 20, 2022

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial in Suzhou (HYML-122)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Feb 6, 2022

Leukemia, Myeloid, Acute Trial in United States (CPX-351, Quizartinib)

Terminated
Has Results
  • Leukemia, Myeloid, Acute
  • Denver, Colorado
  • +4 more
May 10, 2022

Acute Myeloid Leukemia Trial in Suzhou (anti-FLT3 CAR-T)

Recruiting
  • Acute Myeloid Leukemia
  • anti-FLT3 CAR-T
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 29, 2021

Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
  • Cincinnati, Ohio
  • +18 more
Jan 20, 2023

FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • FLT3 Gene Mutation Negative
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Relapsed/Refractory Acute Myeloid Leukemia Trial in Duarte, Palo Alto, Houston (AMG 553)

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • AMG 553
  • Duarte, California
  • +2 more
Dec 22, 2021

Co-existing Mutations on Sorafenib Maintenance Therapy After

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
May 30, 2022

Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate)

Unknown status
  • Acute Myeloid Leukemia
  • Crenolanib besylate
  • Houston, Texas
    MD Anderson Cancer Center
Dec 28, 2020

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)

Recruiting
  • Acute Myeloid Leukemia
  • Fludarabine + Cyclophosphamide + TAA05 Cell Injection
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Jun 29, 2022

Acute Myeloid Leukemia Trial in Germany (FLYSYN)

Completed
  • Acute Myeloid Leukemia
  • FLYSYN
  • Tuebingen, Baden-Wuerttemberg, Germany
  • +4 more
Sep 27, 2021

FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    May 17, 2022

    Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)

    Suspended
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 11, 2022

    Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Gilteritinib 40 MG Oral Tablet
    • +4 more
    • Lexington, Kentucky
      University of Kentucky
    Oct 27, 2022

    Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

    Not yet recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • (no location specified)
    May 24, 2023

    Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

    Recruiting
    • Acute Myeloid Leukemia
    • Miami, Florida
      Miami Cancer Institute at Baptist Health of South Florida
    Jul 27, 2022

    Acute Myeloid Leukemia (AML) Trial in United States (Gilteritinib, Ivosidenib, Enasidenib)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Basking Ridge, New Jersey
    • +6 more
    Mar 3, 2023

    Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in United States (Lanraplenib,

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Los Angeles, California
    • +3 more
    Aug 4, 2022

    AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

    Not yet recruiting
    • AML, Adult
    • +4 more
    • Amiens, France
    • +19 more
    Sep 1, 2023

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

    Recruiting
    • Acute Biphenotypic Leukemia
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Xospata in Relapsed or Refractory Acute Myeloid Leukemia With

    Recruiting
    • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
    • Gilteritinib Exposure
    • Goyang-si, Gyeonggi-do, Korea, Republic of
    • +4 more
    Aug 18, 2022

    Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • Los Angeles, California
    • +7 more
    Mar 14, 2022